In support of this, Nolan et al. reported a contribution of extracellular HSP90 to EMT and invasion in prostate cancer through stimulation of MEK/ERK signaling, leading to EZH2 transcription upregulation followed by the expression of Twist, Snail, and E-cadherin [103]. The gene discussed is HSP90AB1; the disease is prostate carcinoma.